[1] Nakai S, Suzuki K, Masakane I, et al. Overview of regular dialysis treatment in Japan (as of 31 December 2008) [J]. Therapeutic Apheresis and Dialysis, 2010, 14(6): 505-540.[2] Ritz E, Zeng X X, Rychlk I. Clinical manifestation and natural history of diabetic nephropathy [J]. Contributions to Nephrology, 2011, 170: 19-27.[3] Yu Q, Yu H, Huang J B, et al. Distribution and complications of native arteriovenous fistulas in maintenance hemodialysis patients: A single-center study [J]. Journal of Nephrology, 2011, 24(5): 597-603.[4] Wang F, Xing T, Wang N S, et al. A clinical study of pregnancy associated renal insufficiency [J]. Kidney and Blood Pressure Research, 2011, 34(1): 34-40.[5] Wang F, Cheng D S, Wang N S, et al. Continuous glucose monitoring in the patients with diabetic nephropathy [J]. Journal of Shanghai Jiaotong University: Science, 2011, 16(4): 508-512.[6] Konner K. Primary vascular access in diabetic patients: An audit [J]. Nephrology Dialysis Transplantation, 2000, 15(9): 1317-1325.[7] Wang F, Xing T, Wang N S, et al. Clinical significance of plasma CD146 and P-selectin in patients with type 2 diabetic nephropathy [J]. Cytokine, 2012, 57(1): 127-129.[8] Wang F, Bai M, Xing T, et al. Phimosis: A cause of chronic kidney diasease [J]. African Journal of Microbiology Research, 2012, 6(3): 701-703.[9] Woo K, Farber A, Doros G, et al. Evaluation of the efficacy of the transposed upper arm arteriovenous fistula: A single institutional review of 190 basilic and cephalic vein transposition procedures [J]. Journal of Vascular Surgery, 2007, 46(1): 94-99.[10] Hammes M S, Boghosian M E, Cassel K W, et al. Characteristic differences in cephalic arch geometry for diabetic and non-diabetic ESRD patients [J]. Nephrology Dialysis Transplantation, 2009, 24(7): 2190-2194.[11] Racki S, Zaputovic L, Vujicic B, et al. Comparison of survival between diabetic and non-diabetic patients on maintenance hemodialysis: A single-centre experience [J]. Diabetes Research and Clinical Practice, 2007, 75(2): 169-175.[12] Mauri J M, Vela E, Cleries M. Development of a predictive model for early death in diabetic patients entering hemodialysis: A population-based study [J]. Acta Diabetologica, 2008, 45(4): 203-209.[13] Satirapoj B. Review on pathophysiology and treatment of diabetic kidney disease [J]. Journal of the Medical Association of Thailand, 2010, 93(sup6): 228-241.[14] Passadakis P S, Oreopoulos D G. Diabetic patients on peritoneal dialysis [J]. Seminars in Dialysis, 2010, 23(2): 191-197.[15] Segal J H, Kayler L K, Henke P, et al. Vascular access outcomes using the transposed basilic vein arteriovenous fistula [J]. American Journal of Kidney Disease, 2003, 42(1): 151-157.[16] Moon J Y, Jeong K H, Paik S S, et al. Arteriovenous fistula patency associated with angiotensinconverting enzyme I/D polymorphism and ACE inhibition or AT1 receptor blockade [J]. Nephron Clinical Practice, 2009, 111(2): 110-116. |